HL-60 人原髓细胞白血病细胞

HL-60 人原髓细胞白血病细胞

收藏
  • 询价
  • ATCC传代
  • 美国 中国
  • 2025年11月18日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 询价记录
    • 技术资料
    • 供应商

      复祥生物

    • 细胞类型

      普通细胞株-科研实验

    • 物种来源

    • 运输方式

      常温

    • 生长状态

      正常

    • 库存

      大量

    HL-60 人原髓细胞白血病细胞

    IMDM培养基(GIBCO)+20%胎牛血清。细胞货期8-10个工作日

    上海复祥生物提供 ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞|贴壁细胞|悬浮细胞|,细胞库管理规范,提供的细胞株背景清楚,提供参考文献和最优培养条件,网站上有细胞照片,欢迎各位老师来电咨询!联系电话400-821-8510 手机15000266580
    邮箱xiangfbio@163.com.
    详情请登陆http://www.xiangbio.com/

    CCL-240 HL-60 人原髓细胞白血病细胞 的详细介绍

    ATCC® Number: CCL-240™
    Designations: HL-60
    Depositors: RC Gallo
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Homo sapiens (human)
    Morphology: myeloblastic

    CCL-240 HL-60 人原髓细胞白血病细胞


    Source: Organ: peripheral blood
    Disease: acute promyelocytic leukemia
    Cell Type: promyeloblast;
    Cellular Products: tumor necrosis factor (TNF), also known as tumor necrosis factor alpha (TNF-alpha, TNF alpha), after stimulation with phorbol myristic acid [23403]
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

    Applications: transfection host (Nucleofection technology from Lonza
    Roche FuGENE® Transfection Reagents)
    Receptors: complement, expressed [1050]
    Fc, expressed [1050]
    Tumorigenic: Yes
    Reverse Transcript: negative
    Oncogene: myc +
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 13,14
    D13S317: 8,11
    D16S539: 11
    D5S818: 12
    D7S820: 11,12
    THO1: 7,8
    TPOX: 8,11
    vWA: 16
    Cytogenetic Analysis: The stemline chromosome number is pseudodiploid with the 2S component occurring at 6.2%. Five markers (M2 through M6) were common to most S metaphases. DM's, which varied in numbers per cell, occurred in all metaphases karyotyped. HSR chromosomes were not detected.
    Isoenzymes: AK-1, 1
    ES-D, 1
    G6PD, B
    GLO-I, 1
    Me-2, 1
    PGM1, 1
    PGM3, 1
    Age: 36 years
    Gender: female
    Ethnicity: Caucasian
    Comments: HL-60 is a promyelocytic cell line derived by S.J. Collins, et al. Peripheral blood leukocytes were obtained by leukopheresis from a 36-year-old Caucasian female with acute promyelocytic leukemia. [22902]
    HL-60 cells spontaneously differentiate and differentiation can be stimulated by butyrate, hypoxanthine, phorbol myristic acid (PMA, TPA), dimethylsulfoxide (DMSO, 1% to 1.5%), actinomycin D, and retinoic acid. [1229]
    The cells exhibit phagocytic activity and responsiveness to chemotactic stimuli. [1050]
    The line is positive for myc oncogene expression.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 X 10(5) viable cells/ml. Do not allow cell concentration to exceed 1 X 10(6) cells/ml.
    Interval: Maintain cell density between 1 X 10(5) and 1 X 10(6) viable cells/ml.
    Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2005
    recommended serum:ATCC 30-2020
    purified DNA:ATCC CCL-240D
    purified RNA:ATCC CCL-240R
    References: 1050: Gallagher R, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713-733, 1979. PubMed: 288488
    1229: Collins SJ, et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75: 2458-2462, 1978. PubMed: 276884
    22902: Collins SJ, et al. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349, 1977. PubMed: 271272
    23403: Aggarwal BB, et al. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260: 2345-2354, 1985. PubMed: 3871770 CCL-240 HL-60 人原髓细胞白血病细胞
    32237: Nahm MH, et al. Identification of cross-reactive antibodies with low opsonophogocytic activity for Streptoccus pneumoniae. J. Infect. Dis. 176: 698-703, 1997. PubMed: 9291318
    32253: Berninghausen O, Leippe M. Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica. Infect. Immun. 65: 3615-3621, 1997. PubMed: 9284127
    32256: Aparicio CL, et al. Correction for label leakage in fluorimetric assays of cell adhesion. BioTechniques 23: 1056-1060, 1997. PubMed: 9421636
    32277: Mansat V, et al. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral aphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57: 5300-5304, 1997. PubMed: 9393753
    32286: Cuthbert JA, Lipsky PE. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism. Cancer Res. 57: 3498-3504, 1997. PubMed: 9270019
    32290: Michael JM, et al. Resistance to radiation-induced apoptosis in Burkitt's lumphoma cells is associated with defective ceramide signaling. Cancer Res. 57: 3600-3605, 1997. PubMed: 9270034
    32395: Clark RA, et al. Tenascin supports lymphocyte rolling. J. Cell Biol. 137: 755-765, 1997. PubMed: 9151679CCL-240 HL-60 人原髓细胞白血病细胞
    32561: Tiffany HL, et al. Enhanced expression of the eosinophil-derived neurotoin ribonuclease (RNS2) gene requires interaction between the promoter and intron. J. Biol. Chem. 271: 12387-12393, 1996. PubMed: 8647842
    32704: Chan YJ, et al. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus. J. Virol. 70: 8590-8605, 1996. PubMed: 8970984
    32777: Mao M, et al. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc. Natl. Acad. Sci. USA 93: 5910-5914, 1996. PubMed: 8650192
    33019: Lepley RA, et al. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271: 6179-6184, 1996. PubMed: 8626407
    33167: Chen H, et al. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J. Biol. Chem. 271: 15743-15752, 1996. PubMed: 8663022

    CCL-240 HL-60 人原髓细胞白血病细胞

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1800
    上海瓦兰生物科技有限公司
    2025年12月31日询价
    ¥1600
    上海中乔新舟生物科技有限公司
    2025年12月19日询价
    ¥600
    上海烜雅生物科技有限公司
    2025年09月09日询价
    ¥1690
    优利科(上海)生命科学有限公司
    2025年12月09日询价
    HL-60 人原髓细胞白血病细胞
    询价